Drug Shortage Report for DUREZOL
| Report ID | 46280 |
| Drug Identification Number | 02415534 |
| Brand name | DUREZOL |
| Common or Proper name | DUREZOL .05% EMUL 5ML TRD |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | Difluprednate |
| Strength(s) | 0.05% |
| Dosage form(s) | EMULSION |
| Route of administration | OPHTHALMIC |
| Packaging size | 5ML |
| ATC code | S01BA |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2018-04-18 |
| Actual start date | 2018-04-18 |
| Estimated end date | 2018-05-04 |
| Actual end date | 2018-04-19 |
| Shortage status | Resolved |
| Updated date | 2018-04-20 |
| Company comments | Delay in testing |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2018-04-20 | English | Compare |
| v6 | 2018-04-19 | French | Compare |
| v5 | 2018-04-19 | English | Compare |
| v4 | 2018-04-19 | English | Compare |
| v3 | 2018-04-18 | French | Compare |
| v2 | 2018-04-18 | English | Compare |
| v1 | 2018-04-18 | English | Compare |
Showing 1 to 7 of 7